Literature DB >> 29985723

Characterization of Epidermal Lipoxygenase Expression in Normal Human Skin and Tissue-Engineered Skin Substitutes.

Carolyne Simard-Bisson1, Lorraine Andrée Parent1, Véronique J Moulin1,2, Bernard Fruteau de Laclos1,3.   

Abstract

Lipoxygenases (LOXs) are enzymes likely to be involved in corneocyte lipid envelope formation and skin barrier function. In humans, mutations in epidermis-type lipoxygenase 3 ( eLOX-3) and 12R-lipoxygenase ( 12R-LOX) genes are associated with autosomal recessive congenital ichthyosis (ARCI), whereas deletion of these genes in mice causes epidermal defects. LOXs also represent a matter of interest in psoriasis as well as in cancer research. However, their expression as well as the exact role of these enzymes in normal human skin have not been fully described. Our goal was to characterize the expression of epidermal LOXs in both normal human skin and Tissue-Engineered Skin Substitutes (TESS) and to consider TESS as a potential model for LOX functional studies. Staining for epidermal differentiation markers and LOXs was performed, in parallel, on normal human skin and TESS. Our results showed similar expression profiles in TESS when compared with native skin for e-LOX3, 12R-LOX, 12S-lipoxygenase (12S-LOX), and 15-lipoxygenase 2 (15-LOX-2) but not for 15-lipoxygenase 1 (15-LOX-1). Because of their appropriate epidermal differentiation and LOX expression, TESS represent an alternative model for future studies on LOX function.

Entities:  

Keywords:  animal use alternative; antibodies; antibody specificity; cell culture techniques; epidermis; ichthyosis; skin diseases-genetic; staining and labeling

Mesh:

Substances:

Year:  2018        PMID: 29985723      PMCID: PMC6213569          DOI: 10.1369/0022155418788117

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  81 in total

1.  The N-terminal domain of the reticulocyte-type 15-lipoxygenase is not essential for enzymatic activity but contains determinants for membrane binding.

Authors:  Matthias Walther; Monika Anton; Martin Wiedmann; Robert Fletterick; Hartmut Kuhn
Journal:  J Biol Chem       Date:  2002-05-09       Impact factor: 5.157

2.  Effects of serum-free culture at the air-liquid interface in a human tissue-engineered skin substitute.

Authors:  Jessica Jean; Geneviève Bernard; Alexandra Duque-Fernandez; François A Auger; Roxane Pouliot
Journal:  Tissue Eng Part A       Date:  2011-01-10       Impact factor: 3.845

3.  Three-Dimensional In Vitro Skin and Skin Cancer Models Based on Human Fibroblast-Derived Matrix.

Authors:  Manuel Berning; Silke Prätzel-Wunder; Jackie R Bickenbach; Petra Boukamp
Journal:  Tissue Eng Part C Methods       Date:  2015-05-07       Impact factor: 3.056

4.  Identification of functional markers in a self-assembled skin substitute in vitro.

Authors:  Bisera Cvetkovska; Nazrul Islam; Francine Goulet; Lucie Germain
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

5.  Lipoxygenase mRNA in cultured human epidermal and oral keratinocytes.

Authors:  H Zhao; B Richards-Smith; A N Baer; F A Green
Journal:  J Lipid Res       Date:  1995-11       Impact factor: 5.922

6.  Cloning of the cDNA for human 12-lipoxygenase.

Authors:  T Izumi; S Hoshiko; O Rådmark; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length.

Authors:  Katja-Martina Eckl; Rotem Tidhar; Holger Thiele; Vinzenz Oji; Ingrid Hausser; Susanne Brodesser; Marie-Luise Preil; Aysel Onal-Akan; Friedrich Stock; Dietmar Müller; Kerstin Becker; Ramona Casper; Gudrun Nürnberg; Janine Altmüller; Peter Nürnberg; Heiko Traupe; Anthony H Futerman; Hans C Hennies
Journal:  J Invest Dermatol       Date:  2013-04-02       Impact factor: 8.551

8.  A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation.

Authors:  Z Nemes; L N Marekov; L Fésüs; P M Steinert
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

9.  Aloxe3 knockout mice reveal a function of epidermal lipoxygenase-3 as hepoxilin synthase and its pivotal role in barrier formation.

Authors:  Peter Krieg; Sabine Rosenberger; Silvia de Juanes; Susanne Latzko; Jin Hou; Angela Dick; Ulrich Kloz; Frank van der Hoeven; Ingrid Hausser; Irene Esposito; Manfred Rauh; Holm Schneider
Journal:  J Invest Dermatol       Date:  2012-07-26       Impact factor: 8.551

10.  A mouse mutation in the 12R-lipoxygenase, Alox12b, disrupts formation of the epidermal permeability barrier.

Authors:  Jennifer L Moran; Haiyan Qiu; Annick Turbe-Doan; Yujuan Yun; William E Boeglin; Alan R Brash; David R Beier
Journal:  J Invest Dermatol       Date:  2007-04-12       Impact factor: 8.551

View more
  3 in total

Review 1.  The Biosynthesis of Enzymatically Oxidized Lipids.

Authors:  Ali A Hajeyah; William J Griffiths; Yuqin Wang; Andrew J Finch; Valerie B O'Donnell
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-19       Impact factor: 5.555

2.  Investigating the effects of two novel 4-MMPB analogs as potent lipoxygenase inhibitors for prostate cancer treatment.

Authors:  Sonia Iranpour; Aseel Kamil Mohammed Al-Mosawi; Ahmad Reza Bahrami; Hamid Sadeghian; Maryam M Matin
Journal:  J Biol Res (Thessalon)       Date:  2021-05-04       Impact factor: 1.889

Review 3.  Current knowledge of the implication of lipid mediators in psoriasis.

Authors:  Mélissa Simard; Sophie Morin; Zainab Ridha; Roxane Pouliot
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.